CLINICAL STUDY
Comparison of ethanol septal reduction therapy with surgical myectomy for the treatment of hypertrophic obstructive cardiomyopathy
Sherif F. Nagueh, MD, FACC*,*,
Steve R. Ommen, MD ,
Nasser M. Lakkis, MD, FACC*,
Donna Killip, RN*,
William A. Zoghbi, MD, FACC*,
Hartzell V. Schaff, MD, FACC,
Gordon K. Danielson, MD, FACC,
Miguel A. Quiñones, MD, FACC*,
A. J. Tajik, MD, FACC and
William H. Spencer, III, MD, FACC*
* Section of Cardiology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA
Divisions of Cardiology and Cardiothoracic Surgery, Mayo Clinic, Rochester, Minnesota, USA
Manuscript received January 25, 2001;
revised manuscript received August 6, 2001,
accepted August 15, 2001.
* Reprint requests and correspondence: Dr. Sherif F. Nagueh, 6550 Fannin Street, SM-1246, Houston, Texas 77030-2717 USA
sherifn{at}bcm.tmc.edu
OBJECTIVES
This study was designed to compare the hemodynamic efficacy of nonsurgical septal reduction therapy (NSRT) by intracoronary ethanol with standard therapy (surgical myectomy) for the treatment of hypertrophic obstructive cardiomyopathy (HOCM).
BACKGROUND
Nonsurgical septal reduction therapy has gained interest as a new treatment modality for patients with drug-refractory symptoms of HOCM; however, its benefits in comparison to surgery are unknown.
METHODS
Forty-one consecutive NSRT patients at Baylor College of Medicine with one-year follow-up were compared with age- and gradient-matched septal myectomy patients at the Mayo Clinic. All patients had left ventricular outflow obstruction with a resting gradient  40 mm Hg and none had concomitant procedures.
RESULTS
There were no baseline differences in New York Heart Association class, severity of mitral regurgitation, use of cardiac medications or exercise capacity. One death occurred during NSRT because of dissection of the left anterior descending artery. At one year, all improvements in both groups were similar. After surgical myectomy, more patients were on medications (p < 0.05) and there was a higher incidence of mild aortic regurgitation (p < 0.05). After NSRT, the incidence of pacemaker implantation for complete heart block was higher (22% vs. 2% in surgery; p = 0.02). However, seven of the nine pacemakers in the NSRT group were implanted before a modified ethanol injection technique and the use of contrast echocardiography.
CONCLUSIONS
Nonsurgical septal reduction therapy resulted in a significantly higher incidence of complete heart block, but the risk was reduced with contrast echocardiography and slow ethanol injection. Surgical myectomy resulted in a significantly higher incidence of mild aortic regurgitation. Nonsurgical septal reduction therapy, guided by contrast echocardiography, is an effective procedure for treating patients with HOCM. The hemodynamic and functional improvements at one year are similar to those of surgical myectomy.
|
Abbreviations and Acronyms
| | ANOVA | = analysis of variance | | CCS | = Canadian Cardiovascular Society | | EDD | = end-diastolic dimension | | ESD | = end-systolic dimension | | HOCM | = hypertrophic obstructive cardiomyopathy | | ICD | = implantable cardiac defibrillator | | LVOT | = left ventricular outflow tract | | METS | = metabolic equivalents | | NSRT | = nonsurgical septal reduction therapy | | NYHA | = New York Heart Association | | VO2 peak | = maximal oxygen consumption |
|
This article has been cited by other articles:
|
|
|
|
 
S. Haruki, Y. Minami, K. Kajimoto, B. Yashiro, T. Suzuki, M. Kawana, and N. Hagiwara
Possible acute and chronic synergistic effect of dual chamber pacing and disopyramide in obstructive hypertrophic cardiomyopathy: a case report
Eur J Heart Fail,
November 25, 2009;
(2009)
hfp166v1.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. Alam, H. Dokainish, and N. M. Lakkis
Hypertrophic obstructive cardiomyopathy-alcohol septal ablation vs. myectomy: a meta-analysis
Eur. Heart J.,
May 1, 2009;
30(9):
1080 - 1087.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F. A. Cuoco, W. H. Spencer III, V. L. Fernandes, C. D. Nielsen, S. Nagueh, J. L. Sturdivant, R. B. Leman, J. M. Wharton, and M. R. Gold
Implantable Cardioverter-Defibrillator Therapy for Primary Prevention of Sudden Death After Alcohol Septal Ablation of Hypertrophic Cardiomyopathy
J. Am. Coll. Cardiol.,
November 18, 2008;
52(21):
1718 - 1723.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Sorajja, R. A. Nishimura, S. R. Ommen, C. S. Rihal, B. J. Gersh, and D. R. Holmes Jr
Effect of Septal Ablation on Myocardial Relaxation and Left Atrial Pressure in Hypertrophic Cardiomyopathy: An Invasive Hemodynamic Study
J. Am. Coll. Cardiol. Intv.,
October 1, 2008;
1(5):
552 - 560.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
V. L. Fernandes, C. Nielsen, S. F. Nagueh, A. E. Herrin, C. Slifka, J. Franklin, and W. H. Spencer III
Follow-Up of Alcohol Septal Ablation for Symptomatic Hypertrophic Obstructive Cardiomyopathy: The Baylor and Medical University of South Carolina Experience 1996 to 2007
J. Am. Coll. Cardiol. Intv.,
October 1, 2008;
1(5):
561 - 570.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S R Ommen, P M Shah, and A J Tajik
Left ventricular outflow tract obstruction in hypertrophic cardiomyopathy: past, present and future
Heart,
October 1, 2008;
94(10):
1276 - 1281.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Sorajja, U. Valeti, R. A. Nishimura, S. R. Ommen, C. S. Rihal, B. J. Gersh, D. O. Hodge, H. V. Schaff, and D. R. Holmes Jr
Outcome of Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy
Circulation,
July 8, 2008;
118(2):
131 - 139.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Durand, E. Mousseaux, P. Coste, R. Pilliere, O. Dubourg, L. Trinquart, G. Chatellier, A. Hagege, M. Desnos, and A. Lafont
Non-surgical septal myocardial reduction by coil embolization for hypertrophic obstructive cardiomyopathy: early and 6 months follow-up
Eur. Heart J.,
February 1, 2008;
29(3):
348 - 355.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Fifer and G. J. Vlahakes
Management of Symptoms in Hypertrophic Cardiomyopathy
Circulation,
January 22, 2008;
117(3):
429 - 439.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. W. Hansen and N. Merchant
MRI of Hypertrophic Cardiomyopathy: Part I, MRI Appearances
Am. J. Roentgenol.,
December 1, 2007;
189(6):
1335 - 1343.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. W. Hansen and N. Merchant
MRI of Hypertrophic Cardiomyopathy: Part 2, Differential Diagnosis, Risk Stratification, and Posttreatment MRI Appearances
Am. J. Roentgenol.,
December 1, 2007;
189(6):
1344 - 1352.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. W. ElBardissi, J. A. Dearani, R. A. Nishimura, S. R. Ommen, J. M. Stulak, and H. V. Schaff
Septal Myectomy After Previous Septal Artery Ablation in Hypertrophic Cardiomyopathy
Mayo Clin. Proc.,
December 1, 2007;
82(12):
1516 - 1522.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Williams and M. Frenneaux
Syncope in hypertrophic cardiomyopathy: mechanisms and consequences for treatment
Europace,
September 1, 2007;
9(9):
817 - 822.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
I. Olivotto, S. R. Ommen, M. S. Maron, F. Cecchi, and B. J. Maron
Surgical Myectomy Versus Alcohol Septal Ablation for Obstructive Hypertrophic Cardiomyopathy: Will There Ever Be a Randomized Trial?
J. Am. Coll. Cardiol.,
August 28, 2007;
50(9):
831 - 834.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J. Maron
Surgical Myectomy Remains the Primary Treatment Option for Severely Symptomatic Patients With Obstructive Hypertrophic Cardiomyopathy
Circulation,
July 10, 2007;
116(2):
196 - 206.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. A. Fifer
Most Fully Informed Patients Choose Septal Ablation Over Septal Myectomy
Circulation,
July 10, 2007;
116(2):
207 - 216.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. B. King III, T. Aversano, W. L. Ballard, R. H. Beekman III, M. J. Cowley, S. G. Ellis, D. P. Faxon, E. L. Hannan, J. W. Hirshfeld Jr, A. K. Jacobs, et al.
ACCF/AHA/SCAI 2007 Update of the Clinical Competence Statement on Cardiac Interventional Procedures: A Report of the American College of Cardiology Foundation/American Heart Association/American College of Physicians Task Force on Clinical Competence and Training (Writing Committee to Update the 1998 Clinical Competence Statement on Recommendations for the Assessment and Maintenance of Proficiency in Coronary Interventional Procedures)
J. Am. Coll. Cardiol.,
July 3, 2007;
50(1):
82 - 108.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. W. Heldman, K. C. Wu, T. P. Abraham, and D. E. Cameron
Myectomy or Alcohol Septal Ablation: Surgery and Percutaneous Intervention Go Another Round
J. Am. Coll. Cardiol.,
January 23, 2007;
49(3):
358 - 360.
[Full Text]
[PDF]
|
|
|
|
|
|
|
U. S. Valeti, R. A. Nishimura, D. R. Holmes, P. A. Araoz, J. F. Glockner, J. F. Breen, S. R. Ommen, B. J. Gersh, A. J. Tajik, C. S. Rihal, et al.
Comparison of Surgical Septal Myectomy and Alcohol Septal Ablation With Cardiac Magnetic Resonance Imaging in Patients With Hypertrophic Obstructive Cardiomyopathy
J. Am. Coll. Cardiol.,
January 23, 2007;
49(3):
350 - 357.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. J Knight
Alcohol septal ablation for obstructive hypertrophic cardiomyopathy.
Heart,
September 1, 2006;
92(9):
1339 - 1344.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. M. Elliott, J. R. Gimeno, M. T. Tome, J. Shah, D. Ward, R. Thaman, J. Mogensen, and W. J. McKenna
Left ventricular outflow tract obstruction and sudden death risk in patients with hypertrophic cardiomyopathy
Eur. Heart J.,
August 2, 2006;
27(16):
1933 - 1941.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. R. Ommen, B. J. Maron, I. Olivotto, M. S. Maron, F. Cecchi, S. Betocchi, B. J. Gersh, M. J. Ackerman, R. B. McCully, J. A. Dearani, et al.
Long-Term Effects of Surgical Septal Myectomy on Survival in Patients With Obstructive Hypertrophic Cardiomyopathy
J. Am. Coll. Cardiol.,
August 2, 2005;
46(3):
470 - 476.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. H. Yacoub
Surgical Versus Alcohol Septal Ablation for Hypertrophic Obstructive Cardiomyopathy: The Pendulum Swings
Circulation,
July 26, 2005;
112(4):
450 - 452.
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. van der Lee, F. J. ten Cate, M. L. Geleijnse, M. J. Kofflard, C. Pedone, L. A. van Herwerden, E. Biagini, W. B. Vletter, and P. W. Serruys
Percutaneous Versus Surgical Treatment for Patients With Hypertrophic Obstructive Cardiomyopathy and Enlarged Anterior Mitral Valve Leaflets
Circulation,
July 26, 2005;
112(4):
482 - 488.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
R. Roberts and U. Sigwart
Current Concepts of the Pathogenesis and Treatment of Hypertrophic Cardiomyopathy
Circulation,
July 12, 2005;
112(2):
293 - 296.
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Woo, W. G. Williams, R. Choi, E. D. Wigle, E. Rozenblyum, K. Fedwick, S. Siu, A. Ralph-Edwards, and H. Rakowski
Clinical and Echocardiographic Determinants of Long-Term Survival After Surgical Myectomy in Obstructive Hypertrophic Cardiomyopathy
Circulation,
April 26, 2005;
111(16):
2033 - 2041.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Ralph-Edwards, A. Woo, B. W. McCrindle, J. L. Shapero, L. Schwartz, H. Rakowski, E. D. Wigle, and W. G. Williams
Hypertrophic obstructive cardiomyopathy: Comparison of outcomes after myectomy or alcohol ablation adjusted by propensity score
J. Thorac. Cardiovasc. Surg.,
February 1, 2005;
129(2):
351 - 358.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S C Agarwal, I F Purcell, and S S Furniss
Apical myocardial injury caused by collateralisation of a septal artery during ethanol septal ablation
Heart,
January 1, 2005;
91(1):
e2 - e2.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J. Maron, J. A. Dearani, S. R. Ommen, M. S. Maron, H. V. Schaff, B. J. Gersh, and R. A. Nishimura
The case for surgery in obstructive hypertrophic cardiomyopathy
J. Am. Coll. Cardiol.,
November 16, 2004;
44(10):
2044 - 2053.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
F H Gietzen, C J Leuner, L Obergassel, C Strunk-Mueller, and H Kuhn
Transcoronary ablation of septal hypertrophy for hypertrophic obstructive cardiomyopathy: feasibility, clinical benefit, and short term results in elderly patients
Heart,
June 1, 2004;
90(6):
638 - 644.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
C. D. Kimmelstiel and B. J. Maron
Role of Percutaneous Septal Ablation in Hypertrophic Obstructive Cardiomyopathy
Circulation,
February 3, 2004;
109(4):
452 - 456.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, F. J. Ten Cate, et al.
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: a report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines
J. Am. Coll. Cardiol.,
November 5, 2003;
42(9):
1687 - 1713.
[Full Text]
[PDF]
|
|
|
|
|
|
|
Writing Committee Members, B. J. Maron, W. J. McKenna, G. K. Danielson, L. J. Kappenberger, H. J. Kuhn, C. E. Seidman, P. M. Shah, W. H. Spencer III, P. Spirito, et al.
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy: A report of the American College of Cardiology Foundation Task Force on Clinical Expert Consensus Documents and the European Society of Cardiology Committee for Practice Guidelines
Eur. Heart J.,
November 1, 2003;
24(21):
1965 - 1991.
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. M. Chang, S. F. Nagueh, W. H. Spencer III, and N. M. Lakkis
Complete heart block: determinants and clinical impact in patients with hypertrophic obstructive cardiomyopathy undergoing nonsurgical septal reduction therapy
J. Am. Coll. Cardiol.,
July 16, 2003;
42(2):
296 - 300.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. D Grech
Non-coronary percutaneous intervention
BMJ,
July 10, 2003;
327(7406):
97 - 100.
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. V. Sherrid, F. A. Chaudhry, and D. G. Swistel
Obstructive hypertrophic cardiomyopathy: echocardiography, pathophysiology, and the continuing evolution of surgery for obstruction
Ann. Thorac. Surg.,
February 1, 2003;
75(2):
620 - 632.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
W. Shamim, M. Yousufuddin, D. Wang, M. Henein, H. Seggewiss, M. Flather, A. J.S. Coats, and U. Sigwart
Nonsurgical Reduction of the Interventricular Septum in Patients with Hypertrophic Cardiomyopathy
N. Engl. J. Med.,
October 24, 2002;
347(17):
1326 - 1333.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Firoozi, P.M. Elliott, S. Sharma, A. Murday, S.J. Brecker, M.S. Hamid, B. Sachdev, R. Thaman, and W.J. McKenna
Septal myotomy-myectomy and transcoronary septal alcohol ablation in hypertrophic obstructive cardiomyopathy. A comparison of clinical, haemodynamic and exercise outcomes
Eur. Heart J.,
October 2, 2002;
23(20):
1617 - 1624.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. Braunwald, C. E. Seidman, and U. Sigwart
Contemporary Evaluation and Management of Hypertrophic Cardiomyopathy
Circulation,
September 10, 2002;
106(11):
1312 - 1316.
[Full Text]
[PDF]
|
|
|
|
|
|
|
B. J. Maron
Hypertrophic Cardiomyopathy: A Systematic Review
JAMA,
March 13, 2002;
287(10):
1308 - 1320.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
E. D. Wigle, L. Schwartz, A. Woo, and H. Rakowski
To ablate or operate? that is the question!
J. Am. Coll. Cardiol.,
November 15, 2001;
38(6):
1707 - 1710.
[Full Text]
[PDF]
|
|
|
|
